Li-Wei Xu - Search Results

Year	Number of Results
2004	1
2005	4
2006	1
2007	1
2008	2
2009	4
2010	2
2011	4
2012	3
2013	1
2016	1
2017	1
2018	1
2019	2
2020	5
2021	1
2022	1
2024	0

1

Xu LW, Shi YP. Xu LW, et al. J Asian Nat Prod Res. 2011 Jun;13(6):570-4. doi: 10.1080/10286020.2011.575066. J Asian Nat Prod Res. 2011. PMID: 21623523

2

Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.

Ge Y, Xu LW, Liu Y, Sun LY, Gao H, Li JQ, Yang K. Ge Y, et al. Among authors: xu lw. Biomolecules. 2019 Nov 5;9(11):699. doi: 10.3390/biom9110699. Biomolecules. 2019. PMID: 31694268 Free PMC article.

3

Clinical analysis of 132 cases COVID-19 from Wuhan.

Li HY, Wang JW, Xu LW, Zhao XL, Feng JX, Xu YZ. Li HY, et al. Among authors: xu lw. Medicine (Baltimore). 2020 Oct 30;99(44):e22847. doi: 10.1097/MD.0000000000022847. Medicine (Baltimore). 2020. PMID: 33126325 Free PMC article.

4

Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury.

Kong WS, Zhou G, Xu LW, Wang K, Feng YM, Tao LY, Xie RF, Yang M, Zhou X. Kong WS, et al. Among authors: xu lw. Front Pharmacol. 2022 Apr 1;13:868327. doi: 10.3389/fphar.2022.868327. eCollection 2022. Front Pharmacol. 2022. PMID: 35431961 Free PMC article.

5

Transperitoneal laparoscopic adrenalectomy for adrenal metastasis.

Wu HY, Yu Y, Xu LW, Li XD, Yu DM, Zhang ZG, Li GH. Wu HY, et al. Among authors: xu lw. Surg Laparosc Endosc Percutan Tech. 2011 Aug;21(4):271-4. doi: 10.1097/SLE.0b013e318221b6fc. Surg Laparosc Endosc Percutan Tech. 2011. PMID: 21857478

6

Construction, mechanism, and antibacterial resistance insight into polypeptide-based nanoparticles.

Zhen JB, Zhao MH, Ge Y, Liu Y, Xu LW, Chen C, Gong YK, Yang KW. Zhen JB, et al. Among authors: xu lw. Biomater Sci. 2019 Oct 1;7(10):4142-4152. doi: 10.1039/c9bm01050e. Epub 2019 Jul 31. Biomater Sci. 2019. PMID: 31364616

7

Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.

Xiang Y, Chen C, Wang WM, Xu LW, Yang KW, Oelschlaeger P, He Y. Xiang Y, et al. Among authors: xu lw. ACS Med Chem Lett. 2018 Mar 22;9(4):359-364. doi: 10.1021/acsmedchemlett.7b00548. eCollection 2018 Apr 12. ACS Med Chem Lett. 2018. PMID: 29670701 Free PMC article.

8

Multivariate analysis of the prognosis of 37 chondrosarcoma patients.

Yang ZM, Tao HM, Ye ZM, Li WX, Lin N, Yang DS. Yang ZM, et al. Among authors: li wx. Asian Pac J Cancer Prev. 2012;13(4):1171-6. doi: 10.7314/apjcp.2012.13.4.1171. Asian Pac J Cancer Prev. 2012. PMID: 22799300 Free article.

9

Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.

Tao K, Liu J, Liang J, Xu X, Xu L, Mao W. Tao K, et al. Carcinogenesis. 2021 Aug 19;42(8):1056-1067. doi: 10.1093/carcin/bgab051. Carcinogenesis. 2021. PMID: 34128973

10

Metachronous contralateral testicular and bilateral adrenal metastasis of chromophobe renal cell carcinoma: a case report and review of the literature.

Wu HY, Xu LW, Zhang YY, Yu YL, Li XD, Li GH. Wu HY, et al. Among authors: xu lw. J Zhejiang Univ Sci B. 2010 May;11(5):386-9. doi: 10.1631/jzus.B0900250. J Zhejiang Univ Sci B. 2010. PMID: 20443217 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year